TELMIKIND AM

About

TELMIKIND AM is a combination medication designed for the effective management of hypertension, bringing together two distinct classes of antihypertensive agents: Telmisartan, an angiotensin II receptor blocker (ARB), and Amlodipine, a dihydropyridine calcium channel blocker (CCB). Telmisartan works by selectively blocking the AT1 receptor, preventing the vasoconstrictive and aldosterone-secreting effects of angiotensin II, leading to vasodilation and reduced blood pressure. Amlodipine, on the other hand, relaxes vascular smooth muscle by inhibiting the influx of calcium ions, primarily affecting peripheral arterioles and causing vasodilation. This dual mechanism of action provides a synergistic effect, offering more comprehensive and sustained blood pressure control than either component alone. The combination is particularly beneficial for patients whose blood pressure is not adequately controlled with monotherapy, helping to reduce the overall cardiovascular risk associated with chronic hypertension.

Uses

• Treatment of essential hypertension
• Management of high blood pressure
• Reduction of cardiovascular risk
• When monotherapy is insufficient

Directions For Use

Take orally, usually once daily, with or without food, as directed by a physician.

Benefits

• Effective blood pressure control
• Reduced cardiovascular risk
• Improved patient compliance (combination)
• Sustained antihypertensive effect
• Dual mechanism of action
• Potential for fewer side effects than higher doses of monotherapy

Side Effects

• Dizziness
• Headache
• Ankle swelling
• Fatigue
• Flushing
• Nausea
• Abdominal pain
• Palpitations
• Cough
• Muscle cramps
• Orthostatic hypotension
• Peripheral edema

Safety Measures

• Alcohol - May increase the hypotensive effect and risk of dizziness. Use with caution.
• Pregnancy - Contraindicated, especially in the second and third trimesters, due to fetal harm.
• Breastfeeding - Not recommended; consult a doctor as it may pass into breast milk.
• Liver - Use with caution in patients with hepatic impairment; dosage adjustment may be necessary.
• Kidney - Use with caution in patients with renal impairment; monitor kidney function regularly.
• Lung - Generally safe for lung conditions, but monitor for cough (telmisartan).

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.